A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure

International Journal of Cardiology

Volumn 125, Issue 2, 2008, Pages 246-253

  Ahmed, Ali ^a   Young, James B ^b   Love, Thomas E ^c   Levesque, Raynald ^d   Pitt, Betram ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Aon Consulting   (Canada)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Diuretics; Heart failure; Hospitalization; Molrtality; Older adults

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT;

AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DIURETIC THERAPY; DRUG EFFECT; DRUG THERAPY; ELDERLY CARE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC;

EID: 40849130960     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.05.032     Document Type: Article

References (43)

1. Ahmed A., Husain A., Love T.E., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study, using propensity score methods. Eur Heart J 27 (2006) 1431-1439
2. Rosamond W., Flegal K., Friday G., et al. Heart Disease and Stroke Statistics-2007 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
3. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
4. The Digitalis Investigation Group. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Control Clin Trials 17 (1996) 77-97
5. Collins J.F., Howell C.L., and Horney R.A. Determination of vital status at the end of the DIG trial. Control Clin Trials 24 (2003) 726-730
6. Rosenbaum P.R., and Rubin D.B. The central role of propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
7. Rosenbaum P.R., and Rubin D.B. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79 (1984) 516-524
8. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127 (1997) 757-763
9. Rubin D.B. Using propensity score to help design observational studies: application to the tobacco litigation. Health Serv. Outcomes Res. Methodol. 2 (2001) 169-188
10. Rubin D.B. On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 13 (2004) 855-857
11. Normand S.T., Landrum M.B., Guadagnoli E., et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54 (2001) 387-398
12. Levesque R. Macro. In: Levesque R. (Ed). SPSS® Programming and Data Management. 2nd Edition. A Guide for SPSS® and SAS® Users (2005), SPSS Inc, Chicago, IL. http://www.spss.com/spss/data_management_book.htm Available online at: http://www.spss.com/spss/data_management_book.htm. Last access date: June 4, 2005. Vol. 2nd Edition
13. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
14. Love T.E. Using propensity scores: stratification, adjustment, sensitivity and strategies (2005). http://www.chrp.org/propensity/ Available at http://www.chrp.org/propensity/. Last access date: June 4, 2005
15. Rosenbaum P.R. Sensitivity to hidden bias. In: Rosenbaum P.R. (Ed). Observational studies. 2 ed. (2002), Springer-Verlag, New York 110-124
16. Rosenbaum P.R. Sensitivity analysis for matching with multiple controls. Biometrika 75 (1988) 577-581
17. SPSS for Windows, Rel. 14. program (2006), SPSS Inc., Chicago, IL
18. Hunt S.A., Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Endorsed by the Heart Rhythm Society. Published online before print September 13, 2005, doi:10.1161/CIRCULATIONAHA.105.167586. Circulation. 2005;112:e154--e235.
19. Francis G.S., Siegel R.M., Goldsmith S.R., Olivari M.T., Levine T.B., and Cohn J.N. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 103 (1985) 1-6
20. Knight R.K., Miall P.A., Hawkins L.A., Dacombe J., Edwards C.R., and Hamer J. Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease. Br Heart J 42 (1979) 316-325
21. Bayliss J., Norell M., Canepa-Anson R., Sutton G., and Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57 (1987) 17-22
22. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
23. Brilla C.G., Rupp H., Funck R., and Maisch B. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J 16 Suppl O (1995) 107-109
24. Lopez B., Querejeta R., Gonzalez A., Sanchez E., Larman M., and Diez J. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 43 (2004) 2028-2035
25. McCurley J.M., Hanlon S.U., Wei S.K., Wedam E.F., Michalski M., and Haigney M.C. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 44 (2004) 1301-1307
26. Weber K.T. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain. J Am Coll Cardiol 44 (2004) 1308-1310
27. Ahmed A., Rich M.W., Sanders P.W., et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 99 (2007) 393-398
28. Ahmed A., Zannad F., Love T.E., Tallaj J., Gheorghiade M., and Pitt B. A propensity matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28 11 (2007) 1334-1343
29. Gheorghiade M., Abraham W.T., Albert N.M., et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 28 8 (2007) 980-88
30. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. Jama 296 (2006) 2217-2226
31. Domanski M., Norman J., Pitt B., Haigney M., Hanlon S., and Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 42 (2003) 705-708
32. Rowland N.E., and Morian K.R. Roles of aldosterone and angiotensin in maturation of sodium appetite in furosemide-treated rats. Am J Physiol 276 (1999) R1453-R1460
33. Rocha R., and Funder J.W. The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci 970 (2002) 89-100
34. Weber K.T. Aldosterone in congestive heart failure. N Engl J Med 345 (2001) 1689-1697
35. Ahmed A., Rich M.W., Love T.E., et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27 (2006) 178-186
36. Muniz P., Fortuno A., Zalba G., Fortuno M.A., and Diez J. Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth. Nephrol Dial Transplant 16 Suppl 1 (2001) 14-17
37. Cosin J., and Diez J. Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail 4 (2002) 507-513
38. Murray M.D., Deer M.M., Ferguson J.A., et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 111 (2001) 513-520
39. Muller K., Gamba G., Jaquet F., and Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV-efficacy and quality of life. Eur J Heart Fail 5 (2003) 793-801
40. ClinicalTrials.Gov. National Institutes of Health. A comparison of the endpoints of death from a cardiovascular cause and hospitalization for worsening heart failure, in patients who have NYHA Class II heart failure when they are treated with eplerenone or placebo in addition to standard heart failure medicines. http://clinicaltrials.gov/ct/show/NCT00232180?order=4 Accessed July 14, 2007
41. Costanzo M.R., Saltzberg M., O'Sullivan J., and Sobotka P. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 46 (2005) 2047-2051
42. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
43. Gum P.A., Thamilarasan M., Watanabe J., Blackstone E.H., and Lauer M.S. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis. JAMA 286 (2001) 1187-1194